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There is a paucity of published data addressing outcomes of the 
surgical management of inflammatory urethral strictures secondary 
to infection, the main cause of stricture in the developing world.[1,2] 
The aetiology of stricture in the developed world was analysed by 
Lumen et al.,[3] who demonstrated that the main contributing causes 
were instrumentation (32%), idiopathic conditions (23%), urethral 
catheters (13%), trauma (3%) and infection (3%).
Limited literature is available on inflammatory urethral strictures 
secondary to Neisseria gonorrhoeae (gonococcal) infection. In 
available studies, several shortcomings were identified. Firstly, 
analyses and comparison of data on outcomes are complicated by 
the non-uniform nature of urethral strictures that differ in length, 
location and aetiology.[4] Secondly, studies do not distinguish between 
inflammatory and traumatic aetiology. Finally, infective urethral 
strictures have been identified as a risk factor for urethroplasty 
failure.[5] As the inflammatory process differs significantly from other 
causes of urethral obstruction and stricture, published surgical data 
on the selection and outcomes of procedures performed in a non-
inflammatory setting might not be applicable in an inflammatory 
setting. This can explain the high failure rate in the management of 
inflammatory stricture.[5]
The aim of this study was to determine the outcomes of different 
surgical procedures in inflammatory urethral stricture in relation to 
stricture length, position and degree of obliteration of the urethral 
lumen by analysing the success rates after the first interventions 
performed at an academic hospital in central South Africa (SA).
Methods
A retrospective, analytical cohort study of 174 consecutive patients 
who underwent surgical treatment for inflammatory urethral 
strictures between 2007 and 2010 was performed using hospital 
records. Patients with a history of purulent urethral discharge and 
urethral stricture disease were included. Patients with a history of 
trauma, iatrogenic, catheter-related strictures and Lichen sclerosis 
were excluded. Patients were included in this study after a minimum 
of 48 months’ follow-up, which was determined from the day of 
treatment to the last clinic follow-up date.
Outcomes of different surgical procedures for inflammatory 
urethral strictures were analysed in three categories: (i) in relation 
to the length of the stricture; (ii) in relation to the position of 
the stricture; and (iii) whether the stricture was obliterative or 
not. The length of the strictures (in centimetres) was determined 
by retrograde and prograde urethrograms. The location of the 
lesions was documented as penile, penobulbar, bulbar and pan-
urethral. Pan-urethral stricture disease was identified if the patient 
had low-grade strictures throughout the length of the penile and 
bulbar urethra. Lesions were classified as obliterative or non-
obliterative, based on the preoperative retrograde urethrogram 
(RUG). Functional success was assigned if the patient reported 
an improvement in voiding symptoms and urinary quality of life. 
When a patient presented with obstructive lower-urinary tract 
symptoms suggestive of recurrence, a follow-up RUG was performed. 
Treatment failure was defined as recurrence of symptoms requiring 
This open-access article is distributed under 
Creative Commons licence CC-BY-NC 4.0.
Outcome determinants of urethroplasty in the 
management of inflammatory anterior urethral strictures
F M Claassen,1 MMed (Urol), PhD (Urol); S B A Mutambirwa,2 MMed (Urol); L Potgieter,3 PhD (Pharmacol); L Botes,4 PhD;  
H F Kotze,3 PhD (Haematol), DSc; F E Smit,3 MMed (Cardiothorac Surg), PhD
1 Department of Urology, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa
2 Department of Urology, Sefako Makgatho Health Sciences University, and Dr George Mukhari Academic Hospital, Pretoria, South Africa 
3 Department of Cardiothoracic Surgery, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa
4 Department of Health Sciences, Faculty of Health and Environmental Sciences, Central University of Technology, Bloemfontein, South Africa
Corresponding author: F M Claassen (claassen@ufs.ac.za)
Background. Limited data are available on outcomes of the surgical management of inflammatory urethral strictures secondary to infection, 
a major cause of stricture. Several shortcomings that need to be addressed have been identified in the past.
Objective. To determine the impact of stricture length, position and degree of obliterative urethral lumen on the surgical outcomes of 
corrective procedures for inflammatory anterior urethral strictures.
Methods. This retrospective analysis used the records of patients who presented with proven infective anterior urethral strictures at an 
academic hospital from 2007 to 2010. All patients were followed up after 48 months. Urethroplasty outcomes were analysed according to 
stricture location and length and effect of urethral obliteration.
Results. The median age of the 174 patients in the study was 47 (range 21 - 86) years. Anastomotic urethroplasty was successful in 59/99 
(59.6%) patients. Augmented anastomotic urethroplasty was successful in 11/15 (73.3%) patients. Dorsal onlay buccal mucosa graft 
urethroplasty was successful in 23/32 (71.9%) patients, significantly higher than in 2/9 (22.2%) patients who underwent ventral onlay buccal 
mucosa graft urethroplasty (p=0.017; hazard ratio 3.4; 95% confidence interval 1.29 - 9.40). The one-stage circular pedicled penile skin-flap 
urethroplasty was successful in 1/12 (8.3%) patients. Two-stage urethroplasty was successful in 5/7 (71.4%) patients. A primary component 
analysis of the 73 failed procedures showed that stricture length was the main contributor to failure (eigenvalue 1.79; 45%).
Conclusions. Urethroplasty remains a challenge in inflammatory urethral strictures, where stricture length was the main reason for 
treatment failure. 
S Afr Med J 2019;109(12):947-951. https://doi.org/10.7196/SAMJ.2019.v109i12.14003
948       December 2019, Vol. 109, No. 12
RESEARCH
reinvestigation (RUG) or any intervention for stricture recurrence. 
Data were analysed to determine the role of procedure type, length, 
position and obliterative urethral lumens on outcomes and surgical 
management of inflammatory urethral strictures.
Statistical analysis
The Kaplan-Meier estimator was used to calculate failure-specific 
stricture-free rates. Stricture-free rates were measured in months and 
censored on the date that a patient developed stricture recurrence. 
The frequencies were subjected to a χ2 test. Statistical significance 
was set at p<0.05. The effect size was calculated using Cramer’s V 
statistic. This test statistic is used to measure the strength of associa-
tion between two nominal variables, the values ranging between 0 and 1. 
Values close to 0 indicate a weak association and those close to 1 
indicate a strong association between the variables. Analyses were 
done using SPSS version 15.0 (SPSS Inc, USA). A primary component 
analysis (PCA) was performed on the variables in the failed proce-
dures to determine the variables that contributed the most to failure, 
and included stricture length, position and presenting symptoms 
(R software).
Ethical approval
Ethial approval to conduct the study was obtained from the Ethics 
Committee, University of the Free State, Bloemfontein, SA (ref. no. 
ECUFS 124/2015) and relevant managerial members of staff.
Results
Stricture characteristics and procedures
A total of 174 patients (median age 47 (range 21 - 86) years) with 
infective urethral strictures underwent treatment for anterior urethral 
stricture from 2007 to 2010. The location of the urethral strictures 
was as follows: penile (n=17; 9.8%), penobulbar (n=61; 35.1%), 
bulbar (n=68; 39.1%) and pan-urethral (n=28; 16.1%). Patients 
presented with the following symptoms: acute urinary retention 
secondary to obliterated urethral lumens (n=113; 64.9%), obstructive 
lower-urinary tract symptoms with non-obliterated lumens (n=45; 
25.9%) and perineal sepsis (n=16; 9.2%). The median follow-up was 
63 (range 48 - 70) months. The surgical outcomes per procedure are 
presented in Table 1. The overall success rate was 58.0% (101/174).
Dorsal onlay buccal mucosa graft urethroplasty (DBMGU) was 
successful in 23/32 (71.8%) patients, which was significantly higher 
than in 2/9 (22.2%) patients who underwent ventral onlay buccal 
mucosa graft urethroplasty (VBMGU) (p=0.017; hazard ratio (HR) 3.4; 
95% confidence interval (CI) 1.29 - 9.40). One-stage circular pedicled 
penile skin-flap urethroplasty (cPFU) was successful in 1/12 (8.3%) 
patients, and two-stage urethroplasty was successful in 5/7 (71%) 
patients.
Procedures and stricture length 
The success rate of procedures in relation to stricture length is 
summarised in Table 2. Anastomotic urethroplasty (AR), anastomotic 
urethroplasty augmented with buccal mucosa (AAR) and DBMGU 
had success rates of >65%. For stricture lengths of 2.1 - 4.0 cm, the 
most successful outcomes were achieved with DBMGU (81.3%) and 
AAR (75.0%). Two-stage urethroplasty, where buccal mucosal graft 
(BMG) was combined with ventral pedicled penile skin flap, achieved 
a 71% success rate for strictures >4 cm.
Stricture location
As shown in Table 3, AR and AAR were successful in patients with 
strictures in the penobulbar area (65.8% and 71.4%, respectively). 
AAR was successful in 80.0% of patients with strictures in the bulbar 
Table 1. Surgical outcomes analyses of 174 patients treated for inflammatory urethral stricture 
Procedure Patients, n Age, mean (range), years Success rate, n (%) Follow-up, mean (range), months
AR 99 45.9 (21 - 80) 59 (59.6) 59.5 (48 - 70)
AAR 15 43.2 (30 - 76) 11 (73.3) 58 (48 - 65)
DBMGU 32 52.5 (21 - 82) 23 (71.9) 58.3 (48 - 65)
VBMGU 9 47.8 (25 - 73) 2 (22.2) 59 (50 - 62)
cPFU 12 52.4 (35 - 72) 1 (8.3) 60 (48 - 66)
Two-stage urethroplasty 7 45.8 (34 - 68) 5 (71.4) 56 (48 - 58)
AR = anastomotic urethroplasty; AAR = anastomotic urethroplasty augmented with buccal mucosa; DBMGU = dorsal onlay buccal mucosa graft urethroplasty; VBMGU = ventral onlay buccal 
mucosa graft urethroplasty; cPFU = circular pedicled penile skin-flap urethroplasty.
Table 2. Outcomes for specific stricture length groups, excluding perineum urethrostomies and Johanson procedures
Procedure Length, cm Length, mean (range), cm Patients, n Success rate, n (%) p-value CI for effect size w
AR 0.1 - 2.0 1.3 (0.3 - 7.0) 82 53 (64.6) 0.122 w=0.158
2.1 - 4.0 14 6 (42.9) 95% CI 0.00 - 0.36
AAR 0.1 - 2.0 3.1 (1.0 - 6.0) 4 4 (100) 0.273 w=0.316
2.1 - 4.0 8 6 (75.0) 95% CI 0.00 - 0.88
DBMGU 0.1 - 2.0 4.6 (0.6 - 10.0) 7 5 (71.4) 0.599 w=0.110
2.1 - 4.0 16 13 (81.3) 95% CI 0.00 - 0.51
VBMGU 0.1 - 2.0 3.5 (1.0 - 4.5) 2 1 (50.0) 0.346 w=0.333
2.1 - 4.0 6 1 (16.7) 95% CI 0.00 - 1.03
cPFU 0.1 - 2.0 5.0 (3.7 - 7.0) 0 0 (0) Not estimable Not estimable
2.1 - 4.0 4 0 (0)
Two-stage 
urethroplasty
0.1 - 2.0 8.0 (4.0 - 9.0) 0 0 (0) - Sample size too small
2.1 - 4.0 1 1 (100)
CI = confidence interval; AR = anastomotic urethroplasty; AAR = anastomotic urethroplasty augmented with buccal mucosa; DBMGU = dorsal onlay buccal mucosa graft urethroplasty; 
VBMGU = ventral onlay buccal mucosa graft urethroplasty; cPFU = circular pedicled penile skin-flap urethroplasty.
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region. DBMGU achieved a success rate of 76.9% in the penile region, 
with favourable outcomes in the penobulbar (66.7%) and bulbar 
(80.0%) regions. Information of patients with pan-urethral strictures 
are not included in Table 3.
Outcomes of procedures in relation to obliterative v. non- 
obliterative lumens 
AR, AAR and DBMGU had success rates of 64%, 73% and 67%, 
respectively, in patients with obliterative lumens (Table 4).Two-stage 
urethroplasty BMG combined with pedicled penile skin flap had a 
higher success rate than one-stage cPFU in patients with obliterative 
lumens, i.e. 71% and 83%, respectively (p=0.010).
PCA was performed on the 73 patients in whom procedures had 
failed to determine which of the variables (stricture length, position 
and presenting symptoms) contributed significantly to outcome. In 
the 73 patients in whom the first procedures had failed, stricture 
length contributed 45% and position 27% to variance of the data. The 
eigenvalues of these two variables were >1, indicating that the variables 
were the primary components that caused failure. Stricture length – not 
position – was the main contributor in failed urethroplasty: AR (49%), 
DBMGU (74%), VBMGU (59%) and one-stage cPFU (62%).
Discussion
In this study, the long-term outcomes of surgical interventions in 
inflammatory strictures were evaluated. An attempt was made to 
relate outcomes of the specific procedure to the length and location 
of the stricture. The impact on the outcome of whether the stricture 
was obliterative, was also considered.
The overall success rate for endoscopic and urethroplasty proce-
dures was 50%. This finding could be attributed to the postinfective 
inflammatory process and underestimation of stricture length with 
RUG[5] when used as the only imaging modality.[6] In patients with 
infective urethral strictures, urethral ultrasound examination in 
addition to RUG determines the stricture length more accurately, 
and preoperative ultrasonography has been recommended to 
accurately assess the extent of spongiofibrosis in an effort to decrease 
the recurrence rate.[7,8] However, due to anatomical limitations, 
ultrasonography is not recommended as the sole assessment tool for 
strictures and should be combined with urethrography. The use of 
ultrasonography changed the surgical approach in 19% of patients 
in a retrospective study that compared ultrasonography and RUG.[7] 
The best results in our series were obtained when stricture repair 
was augmented with a dorsal onlay BMG in both AAR and DBMGU. 
Table 3. Success rate of procedures for different stricture locations
Procedure Stricture position Patients, n Success rate, n (%) p-value CI for effect size w
AR Penile 1 0 (0) 0.400 w=0.141
Penobulbar 38 25 (65.8) 95% CI 0.00 - 0.32
Bulbar 53 34 (64.2)
AAR Penile 2 2 (100) 0.308 w=0.490
Penobulbar 7 5 (71.4) 95% CI 0.00 - 0.89
Bulbar 5 4 (80.0)
DBMGU Penile 13 10 (76.9) 0.811 w=0.173
Penobulbar 12 8 (66.7) 95% CI 0.00 - 0.39
Bulbar 5 4 (80.0)
VBMGU Penile 1 1 (100) 0.076 w=0.756
Penobulbar 3 1 (33.3) 95% CI 0.00 - 16.50
Bulbar 5 0 (0)
cPFU Penile 2 1 (50.0) 0.141 w=0.674
Penobulbar 8 0 (0) 95% CI 0.00 - 1.14
Bulbar 1 0 (0)
CI = confidence interval; AR = anastomotic urethroplasty; AAR = anastomotic urethroplasty augmented with buccal mucosa; DBMGU = dorsal onlay buccal mucosa graft urethroplasty; 
VBMGU = ventral onlay buccal mucosa graft urethroplasty; cPFU = circular pedicled penile skin-flap urethroplasty.
Table 4. Procedure success rates in non-obliterative and obliterative lumens and perineal sepsis 
Procedure
Non-obliterative 
lumens Obliterative lumens Perineal sepsis
p-value CI for effect size wn Successful, n (%) n Successful, n (%) n Successful, n (%)
AR 17 8 (47) 78 50 (64) 4 1 (25) 0.153 w=0.195
95% CI 0.00 - 13.76
AAR 2 1 (50) 11 8 (77) 2 1 (50) 0.525 w=0.213
95% CI 0.00 - 5.76
Substitution urethroplasty
DBMGU 1 1 (100) 27 18 (67) 4 4 (100) 0.314 w=0.269
95% CI 0.00 - 10.59
VBMGU n/a n/a 9 2 (22) n/a n/a n/a n/a 
cPFU n/a n/a 10 1 (10) 2 0 (0) 0.640 w=0.250
95% CI 0.00 - 5.76
Two-stage urethroplasty n/a n/a 1 1 (10) 6 5 (83) n/a n/a 
CI = confidence interval; AR = anastomotic urethroplasty; AAR = anastomotic urethroplasty augmented with buccal mucosa; DBMGU = dorsal onlay buccal mucosa graft urethroplasty; 
VBMGU = ventral onlay buccal mucosa graft urethroplasty; n/a = not analysed or not applicable; cPFU = circular pedicled penile skin-flap urethroplasty.
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These procedures possibly compensated for the incorrect diagnosis 
of stricture length.
Stricture length remained the main determinator of success of the 
procedures. No difference in outcome of AR for lengths <2 cm or 
≥2 cm in predominantly non-inflammatory strictures was reported.[9] 
Eltahawy et al.[9] reported a 99% success rate in 260 patients with mainly 
trauma- and catheter-related urethral strictures (mean length 1.9 cm) 
located in the bulbar urethra.[9] A trauma-related bulbar stricture 
length of 2 cm is considered ideal to treat by means of AR, with high 
success rates having been reported.[10] However, Morey and Kizer[11] 
reported a 91% success rate in 11 patients with bulbar urethral stric-
tures of 2.6 - 5.0 cm, who underwent AR. Although AR is reserved 
for stricture lengths <2 cm, Aghaji and Odoemene[12] reported a 
success rate of 88% in their group of 98 patients, where the stricture 
length was 3 cm. With regard to inflammatory strictures reported in 
our study, a much lower success rate of 65% with AR was obtained 
in patients with bulbar strictures <2 cm and a relatively low success 
rate of 43% for strictures 2 - 4 cm. AR also had a significantly bet-
ter outcome in strictures <2 cm than in those >2 cm. It is therefore 
apparent from this study that in inflammatory urethral strictures, AR 
should only be considered for shorter stricture lengths and definitely 
in cases of <2 cm.
The AAR technique, which combines the anastomotic urethroplasty 
with substitution graft, has been suggested for bulbar strictures of 
2 - 4 cm.[13] Hoy et al.[14] reported a 96.9% patency rate with a dorsal 
onlay AAR for a mean stricture length of up to 4.6 cm.[14] In our 
study, AAR achieved a success rate of 73% in 15 patients, which 
was markedly lower than the 90% reported previously.[15] A notable 
finding was that AR had a lower success rate (65%) than AAR (100%) 
or DBMGU (71%), even for stricture lengths of 0.1 - 2.0 cm. This 
finding once again raises the question of underestimation of stricture 
length and suggests that AAR and DBMGU procedures compensate 
for this by means of RUG.
The preferred approach of many institutions for bulbar strictures >4 cm 
is circumferential urethral reconstruction with a patch or vascularised flap. 
Whitson et al.[16] reported a 10-year stricture recurrence-free rate of 79% 
in patients who underwent cPFU. However, in our study, contradictory 
results were found in inflammatory strictures, where cPFU had an overall 
success rate of only 8% – much lower than the success rates of DBMGU 
(72%) and two-stage urethroplasty (71%).
Strictures >4 cm were identified as an important risk factor for 
failure. The preferred approach is a circumferential repair with skin 
flaps or grafts.[5,17] The best results for strictures >4 cm were obtained 
with DBMGU (56%) and two-stage urethroplasty (80%).
In this study, infective strictures were located mainly in the bulbar 
and penobulbar urethra, contrary to the penile urethra reported in the 
literature.[18] Stricture location has an effect on stricture length – penile 
strictures tend to be longer than bulbar strictures, with mean stricture 
lengths of 6.1 cm and 3.1 cm, respectively.[18] We found that stricture 
location did not affect treatment outcome. However, penile strictures 
require more complex procedures owing to the thinner spongiosum 
in the penile urethra compared with the bulbar urethra.[4] In patients 
who underwent urethroplasty, the stricture location had no negative 
effect on treatment outcome. This is in contrast to Breyer et al.’s[2] 
findings, where strictures located in the penile urethra had a higher 
recurrence rate after repair.
In this study, obliterative urethral lumens had no negative influence 
on success rates for AR, AAR and dorsal BMG urethroplasties. 
In summary, obliterative urethral lumens played no role in the 
complexity of urethral strictures when urethroplasty was done, 
mainly because the obliterative lumens were excised or augmented 
to a favourable calibre. This is one of the reasons why obliterative 
urethral lumens were excluded from the urethral score validation.[4]
Study limitations
The retrospective nature of this study and because procedures were 
performed by different surgeons, complicated data interpretation. 
The selection of procedures was biased because it was done by different 
surgeons with different skill levels.
Conclusions
Underestimation of inflammatory urethral stricture length was the major 
single contributor towards failed procedures. In general, more invasive 
procedures yielded better results in inflammatory strictures than published 
outcomes of procedures in non-inflammatory lesions. Therefore, AR can 
be considered for lesions <2 cm, AAR for lesions 2 - 3 cm and DBMGU 
for lesions 2 - 4 cm in length. Two-stage urethroplasty is preferable to 
treat patients with stricture lengths >4 cm. Location, and to a lesser extent 
symptoms, played a minor role in failures. In patients with infective 
urethral strictures the placement of the BMG may determine the success 
of substitution urethroplasty. The BMG must be placed dorsally instead 
of ventrally. Obliterative urethral lumens did not have a negative effect 
on the success rate of urethroplasty in patients with infective strictures.
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